FSSNX
Price
$28.74
Change
+$0.14 (+0.49%)
Updated
Jan 23 closing price
Net Assets
27.09B
GMRIX
Price
$12.64
Change
+$0.06 (+0.48%)
Updated
Jan 23 closing price
Net Assets
240.39M
Ad is loading...

FSSNX vs GMRIX

Header iconFSSNX vs GMRIX Comparison
Open Charts FSSNX vs GMRIXBanner chart's image
Fidelity Small Cap Index
Price$28.74
Change+$0.14 (+0.49%)
VolumeN/A
Net Assets27.09B
Nationwide Small Cap Index R6
Price$12.64
Change+$0.06 (+0.48%)
VolumeN/A
Net Assets240.39M
FSSNX vs GMRIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FSSNX vs. GMRIX commentary
Jan 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSSNX is a Hold and GMRIX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
FSSNX has more cash in the bank: 27.1B vs. GMRIX (240M). FSSNX pays higher dividends than GMRIX: FSSNX (1.36) vs GMRIX (1.23). FSSNX was incepted earlier than GMRIX: FSSNX (13 years) vs GMRIX (25 years). GMRIX is a more actively managed with annual turnover of: 15.43 vs. FSSNX (9.00). FSSNX has a lower initial minimum investment than GMRIX: FSSNX (0) vs GMRIX (1000000). FSSNX annual gain was more profitable for investors over the last year : 19.75 vs. GMRIX (15.44). FSSNX return over 5 years is better than : 45.59 vs. GMRIX (32.58).
FSSNXGMRIXFSSNX / GMRIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence13 years25 years-
Gain YTD3.8293.86299%
Front LoadN/AN/A-
Min. Initial Investment01000000-
Min. Initial Investment IRAN/AN/A-
Net Assets27.1B240M11,292%
Annual Yield % from dividends1.361.23111%
Returns for 1 year19.7515.44128%
Returns for 3 years19.4513.07149%
Returns for 5 years45.5932.58140%
Returns for 10 years88.10-7.80-1,129%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MMYT109.446.29
+6.10%
MakeMyTrip Limited
DIN30.930.99
+3.31%
Dine Brands Global
ABBV170.671.47
+0.87%
ABBVIE
UPBD29.750.25
+0.85%
Upbound Group
VTGN2.97-0.02
-0.67%
VistaGen Therapeutics